Aykan, N. F. Et Al. 2013. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.. Medical oncology (Northwood, London, England) , vol.30, no.3 , 679.

Aykan, N. F., Yildiz, İ., Sen, F., Kilic, L., Keskin, S., Ciftci, R., ... Karabulut, S.(2013). Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.. Medical oncology (Northwood, London, England) , vol.30, no.3, 679.

Aykan, N. Et Al. "Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.," Medical oncology (Northwood, London, England) , vol.30, no.3, 679, 2013

Aykan, N. F. Et Al. "Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.." Medical oncology (Northwood, London, England) , vol.30, no.3, pp.679, 2013

Aykan, N. F. Et Al. (2013) . "Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.." Medical oncology (Northwood, London, England) , vol.30, no.3, p.679.

@article{article, author={N. Faruk Aykan Et Al. }, title={Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.}, journal={Medical oncology (Northwood, London, England)}, year=2013, pages={679} }